Raise closed, search for fresh raises on Seedstage

Pebble Beach, CA

Expanding access to mental health services through AI-powered asynchronous consultations.

• Experienced leadership: Led by globally recognized telepsychiatry and digital health experts.
• Proven clinical results: Supported by three clinical trials and 15 peer-reviewed publications.
• Scalable technology: Patent-pending asynchronous consultation platform in use at clinical sites.
• Market opportunity: Positioned within the rapidly growing behavioral health and telehealth markets.
• Customer traction: Early B2B adoption and partnerships with major institutions.

AsyncHealth is raising funds to expand the reach of its AI-powered asynchronous consultation platform designed to transform access to mental health services. The company’s HIPAA-compliant software, “Async,” allows patients to engage with AI-driven virtual agents who gather responses and generate summaries for clinical review, aiming to reduce wait times and administrative burdens on healthcare providers. With a leadership team experienced in telepsychiatry and digital health innovation, AsyncHealth plans to scale its operations, enhance its AI capabilities, and drive broader clinical adoption in 2025.

Backed by three successful clinical trials, 15 peer-reviewed publications, and early customer traction, AsyncHealth is positioned to address a critical gap in mental healthcare access. Its patent-pending approach offers a new model of delivery that could significantly ease clinician workload and improve patient outcomes. The funds raised will support accelerating sales efforts, refining its platform, and responding to the growing demand in the $91 billion behavioral health market. AsyncHealth is committed to shaping the future of mental healthcare through innovative, technology-driven solutions that offer timely and efficient access to care.

Company Info

AsyncHealth enables faster, more accessible mental health consultations using AI-powered asynchronous video interviews.

AsyncHealth is transforming mental healthcare delivery through its HIPAA-compliant, AI-powered asynchronous consultation platform. Instead of traditional appointments, patients record virtual interviews with AI agents, enabling clinicians to review AI-generated clinical summaries and potentially cut diagnosis and treatment times by up to 50%. Already used in clinical environments, the platform is backed by $7M in NIH grants, a patent-pending technology, an exclusive IP agreement, three clinical trials involving 550 patients, and 15 peer-reviewed publications.

Led by top telepsychiatry experts, including former leaders of the American Telemedicine Association and American Psychiatric Association, AsyncHealth is generating early revenue and aims to expand into the $91B behavioral health market in 2025.